BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30591386)

  • 1. Carbapenemases: The never-ending story.
    Martínez-Martínez L
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Feb; 37(2):73-75. PubMed ID: 30591386
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
    Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
    Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare-associated infections due to carbapenemase-producing Enterobacteriaceae: Bacteriological profile and risk factors.
    Chabah M; Chemsi M; Zerouali K; Alloula O; Lehlimi M; Habzi A; Benomar S
    Med Mal Infect; 2016 May; 46(3):157-62. PubMed ID: 26897308
    [No Abstract]   [Full Text] [Related]  

  • 4. The rapid spread of carbapenem-resistant Enterobacteriaceae.
    Potter RF; D'Souza AW; Dantas G
    Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy.
    Iovleva A; Mettus RT; McElheny CL; Griffith MP; Mustapha MM; Pasculle AW; Shields RK; Cooper VS; Doi Y
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance.
    Khan MA; Mohamed AM; Faiz A; Ahmad J
    J Infect Dev Ctries; 2019 Apr; 13(4):334-341. PubMed ID: 32045378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India.
    Sekar R; Srivani S; Kalyanaraman N; Thenmozhi P; Amudhan M; Lallitha S; Mythreyee M
    J Glob Antimicrob Resist; 2019 Sep; 18():207-214. PubMed ID: 31181271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Likelihood of Developing a Carbapenem-Resistant
    Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G; Vila J; Seral C; Castillo FJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.
    Cerqueira GC; Earl AM; Ernst CM; Grad YH; Dekker JP; Feldgarden M; Chapman SB; Reis-Cunha JL; Shea TP; Young S; Zeng Q; Delaney ML; Kim D; Peterson EM; O'Brien TF; Ferraro MJ; Hooper DC; Huang SS; Kirby JE; Onderdonk AB; Birren BW; Hung DT; Cosimi LA; Wortman JR; Murphy CI; Hanage WP
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1135-1140. PubMed ID: 28096418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
    Lodise T; Ye MJ; Zhao Q
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [KPC carbapenemases: what is at stake in clinical microbiology?].
    Cuzon G; Naas T; Nordmann P
    Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic characterization of an emerging bla
    Kerdsin A; Deekae S; Chayangsu S; Hatrongjit R; Chopjitt P; Takeuchi D; Akeda Y; Tomono K; Hamada S
    Sci Rep; 2019 Dec; 9(1):18521. PubMed ID: 31811215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
    Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei.
    Roberts LW; Harris PNA; Forde BM; Ben Zakour NL; Catchpoole E; Stanton-Cook M; Phan MD; Sidjabat HE; Bergh H; Heney C; Gawthorne JA; Lipman J; Allworth A; Chan KG; Chong TM; Yin WF; Schembri MA; Paterson DL; Beatson SA
    Nat Commun; 2020 Jan; 11(1):466. PubMed ID: 31980604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an in-house developed multiplex real-time PCR for the detection of IMP, OXA-23, GES carbapenemases and the transmissible colistin-resistant mcr gene on the BD MAX™ open system.
    Teo JW; Octavia S; Cheng JW; Lin RT
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):67-69. PubMed ID: 29132936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.